본문으로 건너뛰기
← 뒤로

Cerebrovascular complications in pediatric patients with acute lymphoblastic leukemia.

1/5 보강
Scientific reports 📖 저널 OA 94.8% 2025 Vol.15(1) p. 40825
Retraction 확인
출처

Rocka A, Lesniak M, Majka P, Lipniarska J, Suchcicka M, Lejman M, Wozniak M, Zawitkowska J

📝 환자 설명용 한 줄

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, with central nervous system (CNS) complications occurring in approximately 10% of cases.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 18

이 논문을 인용하기

↓ .bib ↓ .ris
APA Rocka A, Lesniak M, et al. (2025). Cerebrovascular complications in pediatric patients with acute lymphoblastic leukemia.. Scientific reports, 15(1), 40825. https://doi.org/10.1038/s41598-025-24634-z
MLA Rocka A, et al.. "Cerebrovascular complications in pediatric patients with acute lymphoblastic leukemia.." Scientific reports, vol. 15, no. 1, 2025, pp. 40825.
PMID 41257979

Abstract

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, with central nervous system (CNS) complications occurring in approximately 10% of cases. This study aimed to analyze cerebrovascular complications in pediatric ALL patients. We conducted a retrospective analysis of 144 pediatric ALL patients treated at the University Children's Hospital in Lublin from 2014 to 2023. Statistical analyses were performed using PQStat software. Among the patients, 12.5% (n = 18) developed cerebrovascular complications, with equal distribution between genders. The median age was 6.3 years. Most complications (83.3%) occurred during induction therapy. The most frequent symptom was seizures (50%), followed by impaired consciousness (39%). Magnetic resonance imaging (MRI) detected ischemic complications in 44.4% of affected patients. No significant correlation was found between risk group, diagnostic parameters, or gender and CNS complications. CNS complications, particularly seizures and ischemic events, are common in pediatric ALL, primarily during induction therapy. MRI plays a crucial role in early detection. Further multicenter studies are necessary to improve management and reduce treatment-related neurotoxicity.

🏷️ 키워드 / MeSH

같은 제1저자의 인용 많은 논문 (1)

🟢 PMC 전문 열기